These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 524104)

  • 21. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE; Humphrey JG; Gordn DA
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of anti-acetylcholine receptor antibodies in myasthenia and its treatment by plasma exchange and immunosuppressants].
    Goulon M; Gajdos P; Goulon C; Bussel A; Morel E; Raimond F; Estournet B
    C R Seances Soc Biol Fil; 1980; 174(4):467-78. PubMed ID: 6449232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT; Long HL; Luo X; Xu JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal myasthenia gravis in the infant of a myasthenic mother in remission.
    Elias SB; Butler I; Appel SH
    Ann Neurol; 1979 Jul; 6(1):72-5. PubMed ID: 574370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acetylcholine receptor antibodies in myasthenia gravis. Measurement of plasma concentration by immunoprecipitation].
    Gammeltoft S; Somnier FE
    Ugeskr Laeger; 1984 Jan; 146(5):352-5. PubMed ID: 6372187
    [No Abstract]   [Full Text] [Related]  

  • 35. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.
    Strober J; Cowan MJ; Horn BN
    Arch Neurol; 2009 May; 66(5):659-61. PubMed ID: 19433668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Arsura EL; Bick A; Brunner NG; Namba T; Grob D
    Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of repeated plasma exchange in myasthenia gravis.
    Newsom-Davis J; Wilson SG; Vincent A; Ward CD
    Lancet; 1979 Mar; 1(8114):464-8. PubMed ID: 85055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab].
    Hayashi R; Tahara M; Oeda T; Konishi T; Sawada H
    Rinsho Shinkeigaku; 2015; 55(4):227-32. PubMed ID: 25904250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission of myasthenia gravis following plasma-exchange.
    Pinching AJ; Peters DK
    Lancet; 1976 Dec; 2(8000):1373-6. PubMed ID: 63848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.